A

Amneal Intermediate Inc
NASDAQ:AMRX

Watchlist Manager
Amneal Intermediate Inc
NASDAQ:AMRX
Watchlist
Price: 8.46 USD -2.76% Market Closed
Market Cap: 2.6B USD
Have any thoughts about
Amneal Intermediate Inc?
Write Note

Amneal Intermediate Inc
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Amneal Intermediate Inc
Operating Expenses Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
A
Amneal Intermediate Inc
NASDAQ:AMRX
Operating Expenses
-$581.8m
CAGR 3-Years
-4%
CAGR 5-Years
-6%
CAGR 10-Years
-12%
Johnson & Johnson
NYSE:JNJ
Operating Expenses
-$36.4B
CAGR 3-Years
1%
CAGR 5-Years
0%
CAGR 10-Years
-2%
Bristol-Myers Squibb Co
NYSE:BMY
Operating Expenses
-$24.4B
CAGR 3-Years
2%
CAGR 5-Years
-24%
CAGR 10-Years
-11%
Pfizer Inc
NYSE:PFE
Operating Expenses
-$28.9B
CAGR 3-Years
0%
CAGR 5-Years
1%
CAGR 10-Years
-2%
Merck & Co Inc
NYSE:MRK
Operating Expenses
-$29.4B
CAGR 3-Years
-14%
CAGR 5-Years
-10%
CAGR 10-Years
-5%
Eli Lilly and Co
NYSE:LLY
Operating Expenses
-$18B
CAGR 3-Years
-11%
CAGR 5-Years
-9%
CAGR 10-Years
-4%

See Also

What is Amneal Intermediate Inc's Operating Expenses?
Operating Expenses
-581.8m USD

Based on the financial report for Dec 31, 2023, Amneal Intermediate Inc's Operating Expenses amounts to -581.8m USD.

What is Amneal Intermediate Inc's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-12%

Over the last year, the Operating Expenses growth was 2%. The average annual Operating Expenses growth rates for Amneal Intermediate Inc have been -4% over the past three years , -6% over the past five years , and -12% over the past ten years .

Back to Top